C4 Therapeutics, Inc. - COM STK (CCCC)

Historical Portfolio Holders from Q4 2020 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM STK
Shares, excl. options Q1 2024
57.4 M
Holdings value Q1 2024
$469 M
Value change Q1 2024
+$89.8 M
Grand Portfolio weight change Q1 2024
+0%
Number of holders
98
Number of buys Q1 2024
63
Number of sells Q1 2024
-51
Average buys Q1 2024 %
+0.001%
Average sells Q1 2024 %
0%
CUSIP
12529R107
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 57.4 M $469 M +$89.8 M $8.17 98
2023 Q4 46.7 M $264 M +$86 M $5.65 87
2023 Q3 34.6 M $64.3 M +$59 K $1.86 81
2023 Q2 34.1 M $93.7 M -$9.38 M $2.75 92
2023 Q1 37.3 M $117 M -$15 M $3.14 115
2022 Q4 39.1 M $230 M -$9.77 M $5.90 108
2022 Q3 39.3 M $345 M -$2.39 M $8.77 109
2022 Q2 38.8 M $292 M -$38.9 M $7.54 107
2022 Q1 36.5 M $885 M +$12.9 M $24.26 114
2021 Q4 34.9 M $1.12 B -$4.99 M $32.20 114
2021 Q3 34.5 M $1.54 B +$109 M $44.68 111
2021 Q2 31.7 M $1.2 B +$211 M $37.84 106
2021 Q1 25.1 M $926 M +$92.3 M $36.99 82
2020 Q4 22.2 M $728 M +$703 M $33.13 73